Important Announcment
June 18, 2026
Nicole Nolen appointed as N1C’s Executive Director

N1C Annual Meeting 2026
Individual Journeys, Shared Discoveries: Partnering for Progress in Individualized Medicine
Hyatt Regency Denver | Denver, CO | October 10, 2026

New FDA Draft Guidance
Plausible Mechanism Framework to Develop Individualized Therapies that Target Specific Genetic Conditions with Known Biological Cause

UK Publishes New Guidance on Rare Therapies
A landmark policy paper outlines the UK’s evolving regulatory approach to individualized and ultra-rare medicines.